Grants per year
Search results
-
Active
-
Prot #VX21‐522‐001: A Phase 1 Single Dose Escalation Study Evaluating the Safety and Tolerability of VX‐522 in Subjects 18 Years of Age and Older With Cystic Fibrosis and a CFTR Genotype Not Responsive to CFTR Modulator Therapy
Jain, M. (PD/PI)
Vertex Pharmaceuticals Incorporated
10/31/23 → 10/31/26
Project: Research project
-
Characterization of the progression of CF-related airway disease via longitudinal transcriptomic analysis of nasal epithelium from children with CF
Jain, M. (Other)
7/1/23 → 6/30/25
Project: Research project
-
Prot #VX20-121-104: A Phase 3, Open-label Study Evaluating the Long-term Safety and Efficacy of VX-121 Combination Therapy in Subjects With Cystic Fibrosis
Jain, M. (PD/PI)
Vertex Pharmaceuticals Incorporated
3/28/23 → 3/28/26
Project: Research project
-
Prot #4D-710-C001: An Open-label, Phase 1/2 Trial of Gene Therapy 4D-710 in Adults with Cystic Fibrosis
Jain, M. (PD/PI)
4D Molecular Therapeutics, Inc.
3/28/23 → 3/28/26
Project: Research project
-
Prot #VX20-121-103: A Phase 3, Randomized, Double-blind, Controlled Study Evaluating the Efficacy and Safety of VX-121 Combination Therapy in Subjects With Cystic Fibrosis Who Are Homozygous for F508del, Heterozygous for F508del and a Gating (F/G) or Resi
Jain, M. (PD/PI)
Vertex Pharmaceuticals Incorporated
1/25/22 → 1/25/26
Project: Research project
-
Prot #VX20-121-102: A Phase 3, Randomized, Double-blind, Controlled Study Evaluating the Efficacy and Safety of VX-121 Combination Therapy in Subjects With Cystic Fibrosis Who Are Heterozygous for F508del and a Minimal Function Mutation (F/MF)
Jain, M. (PD/PI)
Vertex Pharmaceuticals Incorporated
12/13/21 → 6/30/25
Project: Research project
-
Genetic Therapies Working Group
Jain, M. (PD/PI), Jain, M. (PD/PI) & Jain, M. (PD/PI)
4/1/21 → 3/31/25
Project: Research project
-
Prot #VX17-445-105: A Phase 3, Open-label Study Evaluating the Long-term Safety and Efficacy of VX-445 Combination Therapy in Subjects With Cystic Fibrosis Who Are Homozygous or Heterozygous for the F508del Mutation
Jain, M. (PD/PI)
Greenphire, Inc., Vertex Pharmaceuticals Incorporated
7/29/18 → 7/29/26
Project: Research project
-
CFF Teaching and Education Grant
Jain, M. (PD/PI), Jain, M. (PD/PI), Jain, M. (PD/PI), Sala, M. A. (Co-Investigator), Sala, M. A. (Co-Investigator), Sala, M. A. (Co-Investigator), Prickett, M. (Other), Prickett, M. (Other) & Prickett, M. (Other)
7/1/15 → 6/30/25
Project: Research project